ES551013A0 - Procedimiento para la obtencion de nuevas piridopirimidinas - Google Patents

Procedimiento para la obtencion de nuevas piridopirimidinas

Info

Publication number
ES551013A0
ES551013A0 ES551013A ES551013A ES551013A0 ES 551013 A0 ES551013 A0 ES 551013A0 ES 551013 A ES551013 A ES 551013A ES 551013 A ES551013 A ES 551013A ES 551013 A0 ES551013 A0 ES 551013A0
Authority
ES
Spain
Prior art keywords
piridopirimidines
procedure
obtaining new
pyridopyrimidines
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551013A
Other languages
English (en)
Other versions
ES8704491A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES551013A0 publication Critical patent/ES551013A0/es
Publication of ES8704491A1 publication Critical patent/ES8704491A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
ES551013A 1985-01-19 1986-01-17 Procedimiento para la obtencion de nuevas piridopirimidinas Expired ES8704491A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853501696 DE3501696A1 (de) 1985-01-19 1985-01-19 Pyridopyrimidine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES551013A0 true ES551013A0 (es) 1987-04-01
ES8704491A1 ES8704491A1 (es) 1987-04-01

Family

ID=6260235

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551013A Expired ES8704491A1 (es) 1985-01-19 1986-01-17 Procedimiento para la obtencion de nuevas piridopirimidinas

Country Status (18)

Country Link
US (1) US4621082A (es)
EP (1) EP0189045B1 (es)
JP (1) JPS61167688A (es)
CN (1) CN1010947B (es)
AT (1) ATE50407T1 (es)
AU (1) AU578783B2 (es)
CA (1) CA1276636C (es)
DE (2) DE3501696A1 (es)
DK (1) DK23386A (es)
ES (1) ES8704491A1 (es)
FI (1) FI81574C (es)
GR (1) GR860117B (es)
HU (1) HU195812B (es)
NO (1) NO164353C (es)
NZ (1) NZ214842A (es)
PH (1) PH22610A (es)
PT (1) PT81860B (es)
ZA (1) ZA86363B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU598093B2 (en) * 1987-02-07 1990-06-14 Wellcome Foundation Limited, The Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
DK0934937T3 (da) 1990-11-30 2002-04-02 Otsuka Pharma Co Ltd Azolderivater som superoxidradikalinhibitor
JPH04260503A (ja) * 1991-02-13 1992-09-16 Sekisui Jushi Co Ltd ピッキングシステム
JP3013905B2 (ja) * 1991-06-28 2000-02-28 花王株式会社 自動倉庫の入出庫方法
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US5405848A (en) * 1993-12-22 1995-04-11 Ortho Pharmaceutical Corporation Substituted thiazolylaminotetrahydropyridopyrimidines derivatives useful as platelet aggregation inhibitors
US6756367B2 (en) 1998-02-03 2004-06-29 Novartis Ag Benzo-oxadiazoles, -thiadiazoles and -1,4-diazines, pharmaceutical compositions containing them and a process for preparing them
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
JP2006515847A (ja) * 2002-12-13 2006-06-08 ニューロジェン・コーポレーション カプサイシン受容体調節剤としてのカルボン酸、ホスフェート又はホスホネート置換キナゾリン−4−イルアミン類縁体
US20070082920A1 (en) * 2005-10-06 2007-04-12 Yongsheng Song NAD+-dependent DNA ligase inhibitors
DE102006026583A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung
DE102006026585A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung
WO2017133542A1 (zh) * 2016-02-04 2017-08-10 江苏恒瑞医药股份有限公司 一种含有吡啶并嘧啶类衍生物或其可药用盐的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3021332A (en) * 1954-01-04 1962-02-13 Burroughs Wellcome Co Pyrido (2, 3-d) pyrimidine compounds and method of making
GB1129084A (en) * 1965-02-18 1968-10-02 Wellcome Found Novel pyrido[2,3-d]pyrimidines
DE3438350A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung
DE3438351A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-alkoxy-pyrido(2,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
PH22610A (en) 1988-10-17
EP0189045A2 (de) 1986-07-30
US4621082A (en) 1986-11-04
CN1010947B (zh) 1990-12-26
CN86100279A (zh) 1986-11-19
NO164353C (no) 1990-09-26
DK23386A (da) 1986-07-20
EP0189045B1 (de) 1990-02-14
DE3669041D1 (de) 1990-03-22
FI860197A0 (fi) 1986-01-16
NO164353B (no) 1990-06-18
DE3501696A1 (de) 1986-07-24
NO855342L (no) 1986-07-21
ATE50407T1 (de) 1990-02-15
FI81574B (fi) 1990-07-31
JPS61167688A (ja) 1986-07-29
FI81574C (fi) 1990-11-12
HUT40127A (en) 1986-11-28
AU578783B2 (en) 1988-11-03
PT81860B (pt) 1988-05-27
ES8704491A1 (es) 1987-04-01
DK23386D0 (da) 1986-01-17
NZ214842A (en) 1988-07-28
CA1276636C (en) 1990-11-20
PT81860A (en) 1986-02-01
AU5219386A (en) 1986-07-24
EP0189045A3 (en) 1988-10-05
ZA86363B (en) 1986-09-24
HU195812B (en) 1988-07-28
FI860197A (fi) 1986-07-20
GR860117B (en) 1986-05-16

Similar Documents

Publication Publication Date Title
ES551013A0 (es) Procedimiento para la obtencion de nuevas piridopirimidinas
ES510856A0 (es) Procedimiento para la obtencion de nuevos derivados de bispidina.
ES557514A0 (es) Procedimiento para la obtencion de acidos 1-ciclopropil-1,4-dihidro-4-oxo-1,8-naftiridin-3-carboxilicos
ES514340A0 (es) "procedimiento de obtencion de nuevos derivados de piperazina".
ES545155A0 (es) Procedimiento para la obtencion de (pirrol-1-il)-fenil-dihi-dropiridazinona
ES2018208B3 (es) Derivados de hidroxipirazol, procedimiento para su obtencion y su aplicacion contra microorganismos.
ES549383A0 (es) Procedimiento para la obtencion de derivados de 2-aminometil-2-penem.
ES533017A0 (es) Procedimiento para la obtencion de oxazolidinonas trisustituidas
ES553986A0 (es) Procedimiento para la obtencion de compuestos de heterociclil-penem
ES557791A0 (es) Procedimiento para la obtencion de 3-acelaminobenzisotialzol-s,s-dioxidos
ES509958A0 (es) Procedimiento para la obtencion de derivados de aminoacridin (d) y (l)-n-glicosido.
ES552228A0 (es) Procedimiento para la obtencion de derivados de sulfonamida
ES519843A0 (es) Procedimiento para la obtencion de derivados de tetrahicro-2 pirimidona metil-sustituidos.
FI873483A (fi) Oxiranpseudooligosackarider, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
ES2019339B3 (es) Procedimiento para la obtencion de halogenuros de acidos carboxilicos
ES533185A0 (es) Procedimiento para la preparacion de nuevos derivados de 2-propanol.
MX5460E (es) Procedimiento para la preparacion electroquimica de amino-2-etil-2-tiofeno
ES538833A0 (es) Procedimiento para la obtencion de derivados de iminometilazolilo
ES546923A0 (es) Procedimiento para la obtencion de derivados de salicilamida
ES2037116T3 (es) Procedimiento para la obtencion de bencilaminoarildihidropiridinlactonas.
ES542418A0 (es) Procedimiento para la obtencion de derivados de quinoxalina.
ES532084A0 (es) Procedimiento para la obtencion de derivados de isopropilamino-2-propanol
ES517094A0 (es) Procedimiento para la obtencion de colorantes basicos modificados.
ES548522A0 (es) Procedimiento para la obtencion de derivados guanidinicos detiazol
ES519897A0 (es) Procedimiento para la obtencion de derivados de la 2-alcoxi-adenina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203